FENC - NASDAQ

Fennec Pharmaceuticals Inc.

FENC·NASDAQ

$9.35

-6.3%

HealthcareBiotechnology

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$267.13M

EPS-0.3600

P/E Ratio-25.96

Earnings Date08/13/2026

fenc

Additional Paid-In Capital

Last Annual Value

73.61M

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Fennec Pharmaceuticals Inc. Competitors Analysis of Additional Paid-In Capital

FENC · NASDAQ

Company	Additional Paid-In Capital	CAGR 3Y	CAGR 5Y	CAGR 10Y
Fennec Pharmaceuticals Inc. NASDAQ:FENC	73.61M	5.8%	6.7%	5.7%
Orchestra BioMed Holdings, Inc. NASDAQ:OBIO	416.08M	9.5%	34.4%	N/A
Black Diamond Therapeutics, Inc. NASDAQ:BDTX	576.84M	2.6%	5.6%	N/A
Assembly Biosciences, Inc. NASDAQ:ASMB	1.04B	7.9%	5.3%	13.7%
Immuneering Corporation NASDAQ:IMRX	498.66M	25.2%	18.3%	N/A
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	345.84M	18.2%	16.8%	29.8%
Sagimet Biosciences Inc. NASDAQ:SGMT	457.61M	10.3%	69.1%	N/A
Entrada Therapeutics, Inc. NASDAQ:TRDA	0.00	N/A	N/A	N/A
Zura Bio Limited NASDAQ:ZURA	326.08M	26.0%	N/A	N/A
Caribou Biosciences, Inc. NASDAQ:CRBU	718.58M	2.5%	8.1%	N/A
Cartesian Therapeutics, Inc. NASDAQ:RNAC	700.71M	57.6%	8.9%	12.7%

Fennec Pharmaceuticals Inc. Fair Value Envelope

FENC · NASDAQ

Our analysis suggests that FENC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.3467, this represents a potential HIDDEN relative to our calculated worth for Fennec Pharmaceuticals Inc..

HIDDEN

Intrinsic Value

Current Price: $9.3467

Related Guides

Blog Categories

Continue your FENC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.